scorecardresearch
Monday, November 4, 2024
TopicModerna

Topic: moderna

Phase 2 trial of Moderna-Merck’s personalised cancer vaccine shows positive results

Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.

With aim to tackle vaccine inequity, African firm tries to replicate Moderna Covid shot

Afrigen Biologics and Vaccines is relying on the US company’s pledge that it will not enforce its patent during the pandemic.

Moderna, J&J boosters get US CDC’s backing, paving way for next shots

The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.

US FDA clears Moderna, J&J booster shots, allows ‘mix and match’ of Covid vaccines

The Centers for Disease Control & Prevention will consult an expert panel later this week before finalising official recommendations for who should get boosters and when.

Covid pandemic: Philippines approves Moderna for 12-17 year olds, Delta hits Vietnam hard

ThePrint brings you some important global stories on the coronavirus pandemic.

Human trials for the first mRNA HIV vaccine will begin this week. Here’s how it will work

The Covid-19 vaccine giant will enrol humans in two-year-long HIV vaccine trials that begins this week to test for safety and immunogenicity, after promising preliminary results earlier this year.

Moderna’s mRNA vaccine safe & effective in teens, US clinical trial findings show

Among the 2,489 participants who received the mRNA-1273 vaccine, the most common adverse reactions included pain in the injection site, headache and fatigue.

India unlikely to give indemnity to foreign vaccines, may consider only if shortage persists

Modi govt is not inclined to give Moderna or any other foreign vaccine manufacturer indemnity as long as the vaccine programme's target seems achievable by current supply.

15 crore vaccine doses expected in August delays plan of 1 crore daily shots

Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.

Second mRNA vaccine shot safe for people who had allergic reactions to first shot: US study

Of the 189 patients who participated in the study, 130 received the Moderna vaccine, while 59 got the Pfizer-BioNTech vaccine. Second dose was administered to 159 subjects.

On Camera

Kashmiri jihadists more resilient than we think. Rebuilding J&K Police is key to counter them

The new jihadists in J&K have harried Indian forces, staged a series of ambushes, and now begun to target Indian civilian infrastructure projects.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

Indian firms sanctioned by US didn’t violate laws, says MEA. Hyderabad firm that supplied to Army on list

Among 19 Indian firms sanctioned by US Treasury Dept was Lokesh Machines Ltd accused of coordinating with 'Russian defence procurement agent to import Italy-origin CNC machines'.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.